Grupo Fleury
Quezia Souza is a seasoned financial analyst with extensive experience in managing financial processes, including accounts payable and receivable, bank reconciliation, and invoicing. At Grupo Fleury since November 2018, Quezia holds the position of senior financial analyst. Previously, Quezia worked at Cruzeiro Newmarc Patentes E Marcas as a financial analyst, focusing on process administration and reporting. Besides, Quezia served as a senior financial analyst at Fundação de Apoio à Universidade Federal de São Paulo, where responsibilities included direct support to the executive board and payment authorizations. Quezia holds a Bachelor's degree in Business Administration from Uniradial and a postgraduate degree in Business Management from Centro Universitário Católico Italo Brasileiro.
This person is not in any teams
This person is not in any offices
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.